Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5739|1|2|183-190

ISSN： 1567-2026

Source： Current Neurovascular Research, Vol.1, Iss.2, 2004-04, pp. : 183-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alcoholism and its Effects on the Central Nervous System

By  

Current Neurovascular Research, Vol. 10, Iss. 3, 2013-08 ,pp. : 256-262

Bentham Science Publishers

Access to resources Recommend Favorite

Gender Hormones: Role in the Pathogenesis of Central Nervous System Disease and Demyelination

By  

Current Neurovascular Research, Vol. 5, Iss. 4, 2008-11 ,pp. : 224-235

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets to Promote Central Nervous System Regeneration

By  

Current Neurovascular Research, Vol. 1, Iss. 1, 2004-01 ,pp. : 61-75

Bentham Science Publishers

Access to resources Recommend Favorite

Aquaporin Water Channels in Central Nervous System

By  

Current Neurovascular Research, Vol. 1, Iss. 4, 2004-10 ,pp. : 293-303

Bentham Science Publishers

Access to resources Recommend Favorite

From the Editor's Perspective: Inflammatory Glial Cells of the Nervous System: Assistants or Assassins?

By  

Current Neurovascular Research, Vol. 2, Iss. 3, 2005-07 ,pp. : 187-188

Bentham Science Publishers

Access to resources Recommend Favorite